bloodthinners

Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast
Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast
Fierce Biotech
Bayer
asundexian
bloodthinners
Eliquis
clinical trials
Flag link:
Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients
Bristol Myers, J&J plan tests of new blood thinner in nearly 50,000 patients
BioPharma Dive
Bristol Myers Squibb
JNJ
clinical trials
Librexia
bloodthinners
Flag link:
Bayer begins key tests for closely watched blood thinner
Bayer begins key tests for closely watched blood thinner
BioPharma Dive
Bayer
clinical trials
bloodthinners
asundexian
Flag link:
Anthos doubles down on its novel blood thinner
Anthos doubles down on its novel blood thinner
EP Vantage
Anthos
Novartis
Factor XI inhibitor
bloodthinners
abelacimab
Flag link:
Merck, seeking XI factor in race with Bayer, gets FDA fast-track tag for anticoagulant
Merck, seeking XI factor in race with Bayer, gets FDA fast-track tag for anticoagulant
Fierce Biotech
Merck
Bayer
FDA
MK-2060
end-stage renal disease
ESRD
bloodthinners
Flag link:
ESC 2022 preview – who’s got the XI factor?
ESC 2022 preview – who’s got the XI factor?
EP Vantage
ESC 2022
Bristol Myers Squibb
JNJ
Bayer
Eliquis
Xarelto
bloodthinners
Lixiana
Pradaxa
Flag link:
CVS re-adds BMS, Pfizer's Eliquis to formulary after tough negotiations, patient pushback
CVS re-adds BMS, Pfizer's Eliquis to formulary after tough negotiations, patient pushback
Fierce Pharma
CVS Health
Bristol Myers Squibb
Pfizer
Eliquis
formularies
bloodthinners
Flag link:
Running behind Bristol Myers and J&J, Bayer inches forward in the next-gen blood thinner race
Running behind Bristol Myers and J&J, Bayer inches forward in the next-gen blood thinner race
Endpoints
Bayer
bloodthinners
asundexian
clinical trials
Eliquis
Bristol Myers Squibb
JNJ
Flag link:
Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way?
Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way?
Motley Fool
Bristol Myers Squibb
JNJ
clinical trials
bloodthinners
milvexian
Flag link:
ACC 2021: J&J, Bayer pad case for Xarelto in post-surgery artery disease patients
ACC 2021: J&J, Bayer pad case for Xarelto in post-surgery artery disease patients
Fierce Pharma
Bayer
JNJ
ACC
Xarelto
bloodthinners
Flag link:
Pfizer, Bristol Myers' Eliquis flops in post-heart surgery patients, spurring an 'unexplained signal' in certain deaths
Pfizer, Bristol Myers' Eliquis flops in post-heart surgery patients, spurring an 'unexplained signal' in certain deaths
Endpoints
Pfizer
Bristol Myers Squibb
TAVR
bloodthinners
Flag link:
Blood Thinners Could Cut Risk Of Covid-19 Death In Hospital, Study Finds
Blood Thinners Could Cut Risk Of Covid-19 Death In Hospital, Study Finds
Forbes
bloodthinners
COVID-19
Flag link:
AstraZeneca makes case for use of blood thinner Brilinta in stroke patients
AstraZeneca makes case for use of blood thinner Brilinta in stroke patients
Endpoints
AstraZeneca
stroke
Brilinta
clinical trials
bloodthinners
Flag link:
As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis
As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis
Endpoints
Pfizer
Bristol-Myers Squibb
FDA
generics
bloodthinners
Eliquis
Micro Labs
Mylan
Flag link:
ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe
ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe
Fierce Pharma
Pfizer
Bristol-Myers Squibb
Eliquis
Warfarin
bloodthinners
Europe
ESC
European Society of Cardiology
Flag link:
Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlement
Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlement
Fierce Pharma
Sanofi
bloodthinners
Lovenox
generics
Amphastar
Momenta
Sandoz
Flag link:
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Fierce Pharma
Bayer
JNJ
Xarelto
bloodthinners
Bristol-Myers Squibb
Pfizer
Eliquis
Flag link:
J&J snaps up key label expansion for Xarelto
J&J snaps up key label expansion for Xarelto
Biopharma Dive
JNJ
Xarelto
bloodthinners
Eliquis
Janssen
Bayer
Flag link:
Bayer secures approval in the EU for Xarelto® (rivaroxaban) for patients with coronary or peripheral artery disease
Bayer secures approval in the EU for Xarelto® (rivaroxaban) for patients with coronary or peripheral artery disease
Pipeline Review
Europe
Bayer
Xarelto
bloodthinners
Flag link:
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive
BMS, Pfizer's fast-growing Eliquis is about to steamroll market-leader warfarin: executive
Fierce Pharma
Pfizer
Bristol-Myers Squibb
JNJ
Eliquis
Xarelto
Warfarin
bloodthinners
Flag link:

Pages